Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Contamination Control Challenges Facing Cell Therapy Facilities Conor McMorrow at Takeda and Félix Montero-Julian at bioMérieux The presentation aims to provide an overview of challenges that can be faced with the knowledge that a one size fits all approach cannot be taken. Whi... 1 month ago | 101 mins Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... 2 months ago | 55 mins LESSONS & BENEFITS GAINED FROM THE IMPLEMENTATION OF AN AUTOMATED BET SOLUTION Dennis Wong Global at AstraZeneca Liverpool UK and Jordi Iglesias at Charles River The webinar will provide an insight into a global deployment program for an automated solution for Endotoxin testing. A range of implementation aspect... 3 months ago | 74 mins RFC Implementation Strategy For Endotoxin Testing Lindsey Silva and Evelyn Der, at Genentech and Kevin L. Williams at bioMérieux Presented by Lindsey Silva, Ph.D. Director, Microbiology in Analytical Sciences at Genentech, Evelyn Der, Senior QC Scientist at Genentech and Kevin L... November 7, 2023 6:00pm Considerations For Sterility Test Methods When Working With CDMOs Miriam Guest at AstraZeneca, Anne Weeks at Merck KGaA and Chris Berridge at Ecolab The confirmation of microbial quality of drug products manufactured by contract manufacturing organisations (CMOs) is a key component of product relea... September 14, 2023 2:00pm We Are Going Back to the Future with Rapid Methods Dr. Michael J. Miller, at Microbiology Consultants, LLC and Félix Montero-Julian, Scientific Director at bioMérieux Rapid methods have been available to the pharmaceutical industry for decades. And although global regulations have changed to encourage their use, esp... 1 year ago | 111 mins Regulatory Strategies For Rapid Sterility Testing... Dr. Michael J. Miller, at Microbiology Consultants, LLC and Lori Daane, at bioMérieux Full Title: Regulatory Strategies For Rapid Sterility Testing of Gene and Cell Therapy Products The need to utilize rapid sterility testing is gainin... 1 year ago | 122 mins Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release... John Duguid at Vericel Corporation, Lori Daane at bioMerieux and Mike Brewer at Thermo Fisher Scientific Full Title: Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review 7 months ago | 132 mins Just in Time Release of CAR T Cell Therapies Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene The views and opinions expressed during the Webinar are those of the presenter. C... 4 years ago | 77 mins Points To Consider: Demonstrating Comparability Between Recombinant... Karen Zink McCullough at MMI Associates, Nicola Reid at Charles River Labs and Veronika Wills, At Associates of Cape Cod, Inc Full Title: Points To Consider: Demonstrating Comparability Between Recombinant and Lysate Reagent For BET Testing 2 years ago | 123 mins Load more
